| Moderate to severe atopic dermatitis (eczema) |
| Steroid-resistant or recurrent dermatitis |
| Chronic inflammatory skin conditions |
| Maintenance therapy to prevent flare-ups |
Ointment
This ointment contains Tacrolimus, a topical calcineurin inhibitor indicated for moderate to severe atopic dermatitis. It works by suppressing the immune response in the skin, thereby reducing inflammation, redness, and itching.
Unlike topical corticosteroids, Tacrolimus does not cause skin atrophy, making it suitable for long-term use and application on sensitive areas such as the face, neck, and skin folds. It helps restore the skin barrier and provides sustained relief from eczema symptoms.
| Speciality | Dermatology | Immunomodulator |
|---|---|
| Tags | Eczema Treatment | Steroid-free | Anti-inflammatory |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.